Prognostische Bedeutung seltener Einzelchromosomenanomalien bei myelodysplastischen Syndromen
Prognostic impact of rare single chromosomatic anomalities at myelodysplastic syndroms
von Bärbel Christa Elfriede Rothmann
Datum der mündl. Prüfung:2020-01-15
Erschienen:2020-01-03
Betreuer:PD Dr. Julie Schanz
Gutachter:Prof. Dr. Heidi Eva Hahn
Gutachter:Prof. Dr. Margarete Schön
Dateien
Name:Diss.final6.19 schnelle Webanzeige.pdf
Size:1.12Mb
Format:PDF
Description:Dissertation
Zusammenfassung
Englisch
Cytogenetic in myelodysplastic syndromes offer a valid prognostic factor for OS and AML free survival in the IPSS-R. For roughly 90% of cytogenetic abnormalities the prognostic impact is already known. This analysis therefore deals with some of these rare single abnormalities within the remaining 10%. More than 7000 cases where screened. Core results refer to the del(13q) and balanced translocations with a significantly better survival rate and to abnormalities at chromosomes 20 (without del (20q)) and patients with monosomie 9 which have a significantly shorter overall survival rate. For monosomie 9 patients and such with chromosome 20 abnormalities this applies for the AML free survival as well.
Keywords: myelodysplastic syndrom; rare single chromosomic abnormalities